Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
International Hypoglycaemia Study Group
Lancet Diabetes Endocrinol. 2019 May;7(5):385-396.
https://doi.org/10.1016/S2213-8587(18)30315-2

Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up.
Elliott MD, Heitner JF, Kim H, Wu E, Parker MA, Lee DC, Kaufman DB, et al.
Diabetes Care. 2019 Apr 22. pii: dc182266.
https://doi.org/10.2337/dc18-2266

Evidence‐based diabetes care for older people with Type 2 diabetes: a critical review
Sinclair AJ, Abdelhafiz, A, Forbes A, Munshi M
Diabetic  Medicin 2019 Abril:vol 36: (4): 399-413
https://doi.org/10.1111/dme.13859

The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study)
Laiteerapong N, Ham S, Gao Y, Howard H. Moffet, J, Elbert S and Karter A
Diabetes Care 2019 Mar; 42 (3): 416-426.
https://doi.org/10.2337/dc17-1144

Interpretation of HbA1c in primary care and potential influence of anaemia and chronic kidney disease: an analysis from the Copenhagen Primary Care Laboratory (CopLab) Database
Borg R,Persson R, Siersma V, Lind B, Olivarius N, Andersen C
https://doi.org/10.1111/dme.13776

Standars of medical care in Diabetes-2019
January 01 2019; volume 42 issue Supplement 1
https://doi.org/10.2337/dc19-Sint01

Management of Hyperglycemia in Type 2 Diabetes, 2018.
A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Davies M, D’Alessio,D Fradkin J et al
Diabetes Care 2018 Sep dci180033
https://doi.org/10.2337/dci18-0033

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott S, Raz I, Bonaca et al for the DECLARE–TIMI 58 Investigators
The New England Journal of Medicine Downloaded from nejm.org on November 12, 2018.
https://www.nejm.org/doi/full/10.1056/NEJMoa1812389

Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study.
Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG.
Diabetes Care. 2018 Oct;41(10):2127-2135.
https://doi.org/10.2337/dc18-0287.

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.
Stefan N, Häring HU, Cusi K.
Lancet Diabetes Endocrinol. 2018 Aug 30. pii: S2213-8587(18)30154-2.
https://doi.org/10.1016/S2213-8587(18)30154-2